Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases

Journal of clinical and experimental hematopathology : JCEH

Volumn 53, Issue 3, 2013, Pages 197-205

  Hashimoto, Yoko ^a   Yokohama, Akihiko ^a   Saitoh, Akio ^a   Nakahashi, Hirotaka ^a   Toyama, Kohtaro ^a   Mitsui, Takeki ^a   Koiso, Hiromi ^a   Saitoh, Takayuki ^a   Handa, Hiroshi ^a   Uchiumi, Hideki ^a   Jinbo, Takahiro ^a   Murayama, Kayoko ^a   Matsumoto, Morio ^a   Sawamura, Morio ^a   Karasawa, Masamitsu ^a   Murakami, Hirokazu ^a   Hirato, Junko ^a   Nojima, Yoshihisa ^a   Kojima, Masaru ^a   Tsukamoto, Norifumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; PREDNISONE; R-CHOP PROTOCOL; VINCRISTINE;

ADULT; AGED; BLOOD; CANCER STAGING; FEMALE; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE;

EID: 84907363006     PISSN: None     EISSN: 18809952     Source Type: Journal    
DOI: 10.3960/jslrt.53.197     Document Type: Article

References (0)